MedTrace Logo

Effects of OAGB and DJB-SG on 10-year and Lifetime Risks of MACE

NCT06254339 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 830

Last updated 2024-02-13

No results posted yet for this study

Summary

Metabolic bariatric surgery (MBS) has demonstrated its efficacy in achieving sustainable weight loss and alleviating associated comorbidities. The primary objective of our investigation is to assess the long-term impact and sustainability of weight loss, the remission of T2D as well as risk prediction of cardiovascular events following MBS concerning one-anastomosis gastric bypass (OAGB) and duodenojejunal bypass with sleeve gastrectomy (DJB-SG).

Conditions

Interventions

PROCEDURE

OAGB

using OAGB procedure as metabolic bariatric surgery

PROCEDURE

DJB-SG

using DJB-SG procedure as metabolic bariatric surgery

Sponsors & Collaborators

  • National Defense Medical Center, Taiwan

    lead OTHER

Principal Investigators

  • Mu-Xian Yu, MD · Tri-Service General Hospital, NDMC

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2017-12-31
Completion
2023-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06254339 on ClinicalTrials.gov